In the last trading session, 0.22 million shares of the GlycoMimetics Inc (NASDAQ:GLYC) were traded, and its beta was 1.82. Most recently the company’s share price was $0.26, and it changed around $0.01 or 3.09% from the last close, which brings the market valuation of the company to $16.77M. GLYC currently trades at a discount to its 52-week high of $3.53, offering almost -1257.69% off that amount. The share price’s 52-week low was $0.14, which indicates that the current value has risen by an impressive 46.15% since then. We note from GlycoMimetics Inc’s average daily trading volume that its 10-day average is 0.32 million shares, with the 3-month average coming to 20.24 million.
GlycoMimetics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended GLYC as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. GlycoMimetics Inc is expected to report earnings per share of 0 for the current quarter.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Instantly GLYC has showed a green trend with a performance of 3.09% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2750 on recent trading dayincreased the stock’s daily price by 5.45%. The company’s shares are currently up 4.42% year-to-date, but still down -1.89% over the last five days. On the other hand, GlycoMimetics Inc (NASDAQ:GLYC) is 8.38% up in the 30-day period. We can see from the shorts that 5.64 million shares have been sold at a short interest cover period of 1.07 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 13.11%.
GLYC Dividends
GlycoMimetics Inc’s next quarterly earnings report is expected to be released in February.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.12% of GlycoMimetics Inc shares, and 47.91% of them are in the hands of institutional investors. The stock currently has a share float of 49.46%. GlycoMimetics Inc stock is held by 45.0 institutions, with BVF INC/IL being the largest institutional investor. By 2024-06-30, it held 14.8071% of the shares, which is about 9.54 million shares worth $2.69 million.
ARTAL GROUP S.A., with 13.3252% or 8.59 million shares worth $2.42 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 1.93 shares worth $0.5 million, making up 2.99% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 730.6 shares worth around $0.19 million, which represents about 1.13% of the total shares outstanding.
